This patent covers, in its broadest issued claim, a type of stem cell that is useful for the generation of neurons. The cell population covered is a culture of cells expressing glial fibrillary acidic protein and nestin. In some dependent claims the cells may be extracted from the medial ganglionic eminence (MGE) and lateral ganglionic eminence (LGE).
This patent is useful if the allogeneic problem can be resolved, since unlike mesenchymal stem cells there is no reason to believe that these cells can be used across allogeneic barriers.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.